These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 34024444)

  • 41. Ridinilazole: a novel therapy for Clostridium difficile infection.
    Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
    Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
    Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
    Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.
    Cross SJ; Morton TH; Wolf J
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S46-S51. PubMed ID: 34791397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent
    Tsigrelis C
    Cleve Clin J Med; 2020 Jun; 87(6):347-359. PubMed ID: 32487555
    [No Abstract]   [Full Text] [Related]  

  • 47. Health care associated Clostridioides difficile infection and colonization in patients admitted at tertiary care hospital Pakistan.
    Ahmed A; Ikram A; Sabir N; Zaman G; Gardeezi A; Satti L
    J Pak Med Assoc; 2022 Apr; 72(4):610-615. PubMed ID: 35614587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.
    Kim MH; Kim YC; Kim JL; Park YS; Kim H
    BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective, observational study of fidaxomicin use for
    Guery B; Berger P; Gauzit R; Gourdon M; Barbut F; ; Dafne Study Group ; Bémer P; Bessède E; Camou F; Cattoir V; Couzigou C; Descamps D; Dinh A; Laurans C; Lavigne JP; Lechiche C; Leflon-Guibout V; Le Monnier A; Levast M; Mootien JY; N'Guyen Y; Piroth L; Prazuck T; Rogeaux O; Roux AL; Vachée A; Vernet Garnier V; Wallet F
    J Int Med Res; 2021 Jun; 49(6):3000605211021278. PubMed ID: 34162264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV; Ozen M; Dinleyici EC; Goh S
    World J Gastroenterol; 2016 Mar; 22(11):3078-104. PubMed ID: 27003987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Cross-Sectional Study of Clostridium Difficile Infection in Inpatients with Antibiotic Associated Diarrhea.
    Ma X; Li Z; Zheng Y; Fang L; Lin H; Xu H; Hong G
    Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic-Specific Risk for Community-Acquired
    Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridioides difficile Colitis.
    Pumiglia L; Wilson L; Rashidi L
    Surg Clin North Am; 2024 Jun; 104(3):545-556. PubMed ID: 38677819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.
    Steele J; Zhang Q; Beamer G; Butler M; Bowlin T; Tzipori S
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4039-41. PubMed ID: 23689716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mechanisms and safety of probiotics against toxigenic
    Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging alternatives against Clostridioides difficile infection.
    Romero-Rodríguez A; Martínez de la Peña C; Troncoso-Cotal S; Guzmán C; Sánchez S
    Anaerobe; 2022 Dec; 78():102638. PubMed ID: 36210608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.
    Chilton CH; Crowther GS; Miossec C; de Gunzburg J; Andremont A; Wilcox MH
    J Antimicrob Chemother; 2020 Jun; 75(6):1458-1465. PubMed ID: 32097465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenicity and virulence of
    Buddle JE; Fagan RP
    Virulence; 2023 Dec; 14(1):2150452. PubMed ID: 36419222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.